Targeting inflammation in osteosarcomas

By Kumar Nair

Inflammation is a central pathway that may act as both cause and effect in a range of musculoskeletal disorders as diverse as arthritis, implant loosening, and bone tumors. For Francis Y. Lee, MD, PhD, the current chair of the AAOS Clinician Scientist Development Program, a better understanding of inflammation may open doors to innovative treatments, particularly for osteosarcomas.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!

Advertisements


Advertisement